858 Therapeutics launches with $60 million and acquisition of …
Sep 20, 2021 · After operating for more than 2 years in stealth, the biotech startup 858 Therapeutics has formally launched with $60 million in series A financing to develop small-molecule drugs for cancer, with ...
OFF
858 Therapeutics Launches With $60 Million And Acquisition Of …
6 days from now
Sep 20, 2021 · After operating for more than 2 years in stealth, the biotech startup 858 Therapeutics has formally launched with $60 million in series A financing to develop small-molecule drugs for cancer, with ...
acs.org
OFF
858 Therapeutics Raises $60 Million - Chemical & Engineering News
6 days from now
Sep 24, 2021 · 858 Therapeutics has launched with $60 million in series A financing to develop small-molecule cancer drugs. The San Diego-based start-up also acquired Gotham Therapeutics for an undisclosed sum.
acs.org
OFF
Bristol Myers, Genentech And Celgene Bought Their Old Biotechs ...
6 days from now
Sep 21, 2021 · Now, the collective is ready for its next venture: launching RNA biotech 858 Therapeutics with a $60 million series A fundraising. Bristol Myers, Genentech and Celgene bought their old biotechs.
fiercebiotech.com
OFF
Calling San Diego: 858 Therapeutics Closes $60M Series A Round To …
6 days from now
Sep 21, 2021 · 858 Therapeutics Inc. emerged from stealth mode, unveiling $60 million in series A funding and plans to drug a series of protein targets involved in modulating RNA biology in cancer. Founding investor Versant Ventures is backing a team of successful drug hunters who …
bioworld.com
OFF
San Diego Biotech Uncloaks With $60 Million To Tackle ... - BioSpace
6 days from now
Sep 21, 2021 · A San Diego-based biotech has exited stealth mode with hopes of treating cancers that are resistant to current therapies. On Tuesday, 858 Therapeutics launched with a $60 million Series A financing round under its belt. The company will use the funds to propel …
biospace.com
OFF
858 Therapeutics Raises $60 Million | C&EN Global Enterprise
6 days from now
Oct 22, 2024 · 858 Therapeutics has launched with $60 million in series A financing to develop small-molecule cancer drugs. The San Diego-based start-up also acquired Gotham Therapeutics for an undisclosed sum. Gotham launched in 2018 to develop drugs based on …
acs.org
OFF
Wilson Sonsini Represents New Enterprise Associates And Versant ...
6 days from now
On September 22, 2021, 858 Therapeutics announced the completion of a $60 million Series A financing led by founding investor Versant Ventures, with participation from NEA, Cormorant Asset Management, and Logos Capital. Wilson Sonsini Goodrich & Rosati represented NEA …
wsgr.com
OFF
News | 858 Therapeutics
6 days from now
December 20, 2023 858 Therapeutics Expands Leadership Team to Support Transition to the Clinic; April 5, 2022 858 Therapeutics Expands Board of Directors and Leadership Team; September 21, 2021 858 Therapeutics Launches with Proven Team and $60 Million Series A …
8five8tx.com
OFF
858 Therapeutics Launches With Proven Team And $60 Million
6 days from now
Sep 21, 2021 · SAN DIEGO--(BUSINESS WIRE)--858 Therapeutics, Inc. today exited stealth mode with a $60 million Series A financing led by founding investor Versant Ventures, with participation from NEA, Cormorant Asset Management and Logos Capital.Proceeds are being …
biospace.com
OFF
A Financing 858 Therapeutics Launches With Proven Team And …
6 days from now
)--858 Therapeutics today exited stealth mode with a $60 million Series A financing led by. founding investor Versant Ventures, with participation from NEA, Cormorant Asset Management and Logos Capital. Proceeds are being used to develop a portfolio of small molecules directed …
versantventures.com
OFF
858 Therapeutics Acquires Gotham Therapeutics - 2021-09-21
6 days from now
GeneOnline News — 858 Therapeutics Launches with $60 Million Series A for Advancing Small-Molecule Drugs . ... Chemical & Engineering News — 858 Therapeutics launches with $60 million and acquisition of Gotham Therapeutics . Unlock even more features with Crunchbase Pro . …
crunchbase.com
OFF
858 Therapeutics Launches With Proven Team And $60 Million …
6 days from now
On September 21, 2021 858 Therapeutics reported that stealth mode with a $60 million Series A financing led by founding investor Versant Ventures, with participation from NEA, Cormorant Asset Management and Logos Capital (Press release, 858 Therapeutics, SEP 21, 2021, View …
1stoncology.com
OFF
Series A - 858 Therapeutics - 2021-09-21 - Crunchbase
6 days from now
Sep 21, 2021 · 858 Therapeutics raised $60000000 on 2021-09-21 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... Business Wire — 858 Therapeutics Launches with Proven Team and $60 …
crunchbase.com
OFF
Wilson Sonsini Advises 858 Therapeutics On IP Matters Related To …
6 days from now
Oct 1, 2024 · On September 26, 2024, San Diego-based 858 Therapeutics, a biotechnology and drug discovery company developing a portfolio of small molecule therapeutics directed against novel oncology and immunology targets, announced the completion of a $50 million Series B …
wsgr.com
OFF
Novartis Raises Sales Outlook For Mid-Term, Acquires Kate …
6 days from now
1 day ago · Over the past 60 days, Pfizer’s earnings estimates have risen from $2.62 to $2.91 per share for 2024, while that for 2025 has increased from $2.85 to $2.92. PFE’s shares have lost 12.2% year ...
nasdaq.com
FAQs about 858 Therapeutics launches with $60 million and acquisition of … Coupon?
What is 858 Therapeutics?
When will 858 Therapeutics start a Phase 1 trial?
Has 858 Therapeutics acquired Gotham Therapeutics?
Who are the founders of 858?
What is a series a grant for 858?
Is 858 a good company to invest in RNA modification?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
